Our research team made patient-specific embryonic stem cells and we have the technology to produce them.

I apologize for creating this uproar both in and out of Korea. The fact remains that our research team was successful in creating stem cells from patients' skin cells. Still, there were mistakes made, human errors, in taking photographs and in the preservation of the stem cells.

I definitely have the source technology to produce tailored embryonic stem cells. I can replicate the process anytime.

I would like to have time to confirm the validity of the technology.

Technology for patient-specific embryonic stem cells belongs to South Korea. And you will find out that this is true.

There is no doubt that we produced 11 patient-specific stem cells and possess the core technology to create them again.